Pexiganan (Locilex) for mild foot infection in diabetic foot ulcers
NIHR HSRIC
Record ID 32016000442
English
Authors' objectives:
Diabetes is a common life-long condition. People with diabetes have very high levels of glucose, a type of sugar, in their blood because their bodies do not make enough insulin or the insulin does not work properly. Diabetes can cause foot problems, such as infections and ulcers. Some people may have their feet amputated if the ulcer or infection is severe.
Pexiganan is a new antibiotic cream for diabetic foot ulcers. Some studies have suggested that pexiganan can treat mild infections in patients with diabetic foot ulcers. More studies are trying to show how well pexiganan works and whether it is safe to use.
If pexiganan is licenced for use in the UK, it could be a new treatment option for patients with diabetic foot ulcers.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
http://www.hsric.nihr.ac.uk/topics/pexiganan-locilex-for-mild-foot-infection-in-diabetic-foot-ulcers/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Humans
- Antimicrobial Cationic Peptides
- Diabetic Foot
- Focal Infection
- Ulcer
Contact
Organisation Name:
NIHR Horizon Scanning Centre
Contact Address:
The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name:
c.packer@bham.ac.uk
Contact Email:
c.packer@bham.ac.uk
Copyright:
NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.